Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a Phase 1b clinical trial investigating the effects of linvoseltamab in combination with other cancer treatments for patients with relapsed/refractory multiple myeloma.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:45.000Z thumbnail image
  6. Check
    8 days ago
    Change Detected
    Summary
    The value of the Primary Completion Date (Estimated) on the webpage has recently changed. This change represents an update in the estimated date when the study is expected to be completed.
    Difference
    0.0%
    Check dated 2024-06-03T13:18:49.000Z thumbnail image
  7. Check
    10 days ago
    Change Detected
    Summary
    The webpage has been updated to include information about a Phase 1b study of REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) plus other cancer treatments for patients with relapsed/refractory multiple myeloma. The study aims to investigate the safety and efficacy of combining linvoseltamab with other cancer therapies in treating multiple myeloma.
    Difference
    6%
    Check dated 2024-06-01T11:49:04.000Z thumbnail image
  8. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including general health conditions and prior treatments, as well as specific inclusion and exclusion criteria for different cohorts. Previously, this section only indicated that no information was provided.
    Difference
    44%
    Check dated 2024-05-22T21:37:32.000Z thumbnail image
  9. Check
    42 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:43:32.000Z thumbnail image

Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.